RU2224505C2 - Использование нанодисперсий в составах для фармацевтического применения - Google Patents

Использование нанодисперсий в составах для фармацевтического применения Download PDF

Info

Publication number
RU2224505C2
RU2224505C2 RU99109958/15A RU99109958A RU2224505C2 RU 2224505 C2 RU2224505 C2 RU 2224505C2 RU 99109958/15 A RU99109958/15 A RU 99109958/15A RU 99109958 A RU99109958 A RU 99109958A RU 2224505 C2 RU2224505 C2 RU 2224505C2
Authority
RU
Russia
Prior art keywords
nanodispersion
component
polyethoxylated
pharmaceutical
fatty acid
Prior art date
Application number
RU99109958/15A
Other languages
English (en)
Russian (ru)
Other versions
RU99109958A (ru
Inventor
Андреас Вернер СУПЕРСАКСО (CH)
Андреас Вернер СУПЕРСАКСО
Ганс Георг ВЕДЕР (CH)
Ганс Георг ВЕДЕР
Дитмар ХЮГЛИН (DE)
Дитмар ХЮГЛИН
Йоахим Фридрих РЁДИНГ (DE)
Йоахим Фридрих РЁДИНГ
Original Assignee
Циба Спешиалти Кемикалз Холдинг Инк.
Везифакт АГ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Циба Спешиалти Кемикалз Холдинг Инк., Везифакт АГ filed Critical Циба Спешиалти Кемикалз Холдинг Инк.
Publication of RU99109958A publication Critical patent/RU99109958A/ru
Application granted granted Critical
Publication of RU2224505C2 publication Critical patent/RU2224505C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU99109958/15A 1998-05-11 1999-05-11 Использование нанодисперсий в составах для фармацевтического применения RU2224505C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810422 1998-05-11
EP98810422.0 1998-05-11

Publications (2)

Publication Number Publication Date
RU99109958A RU99109958A (ru) 2001-03-27
RU2224505C2 true RU2224505C2 (ru) 2004-02-27

Family

ID=8236078

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99109958/15A RU2224505C2 (ru) 1998-05-11 1999-05-11 Использование нанодисперсий в составах для фармацевтического применения

Country Status (20)

Country Link
US (2) US7081253B2 (cg-RX-API-DMAC10.html)
EP (1) EP0956853B1 (cg-RX-API-DMAC10.html)
JP (1) JP4755742B2 (cg-RX-API-DMAC10.html)
KR (1) KR100622285B1 (cg-RX-API-DMAC10.html)
CN (1) CN1220483C (cg-RX-API-DMAC10.html)
AR (1) AR019274A1 (cg-RX-API-DMAC10.html)
AT (1) ATE312597T1 (cg-RX-API-DMAC10.html)
AU (1) AU767896B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI9902068B8 (cg-RX-API-DMAC10.html)
CZ (1) CZ166999A3 (cg-RX-API-DMAC10.html)
DE (1) DE59912910D1 (cg-RX-API-DMAC10.html)
ES (1) ES2253871T3 (cg-RX-API-DMAC10.html)
HU (1) HUP9901570A2 (cg-RX-API-DMAC10.html)
ID (1) ID22565A (cg-RX-API-DMAC10.html)
MY (1) MY133019A (cg-RX-API-DMAC10.html)
PL (1) PL332934A1 (cg-RX-API-DMAC10.html)
RU (1) RU2224505C2 (cg-RX-API-DMAC10.html)
SG (1) SG71923A1 (cg-RX-API-DMAC10.html)
TW (1) TWI241915B (cg-RX-API-DMAC10.html)
ZA (1) ZA993200B (cg-RX-API-DMAC10.html)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908309D0 (en) * 1999-04-12 1999-06-02 Phares Pharm Res Nv Lipid aggregate forming compositions and their use
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
RU2200558C1 (ru) * 2002-04-23 2003-03-20 Нестерук Владимир Викторович Лекарственное средство, содержащее финастерид
AT6609U3 (de) * 2003-04-07 2004-04-26 Unipack Ges M B H Abfuell Und Verfahren zum herstellen einer klaren lecithin enthaltenden oralen zubereitung
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
PL1768650T3 (pl) * 2004-06-04 2009-01-30 Camurus Ab Ciekłe formulacje depot
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
EP2013016B8 (en) 2006-03-29 2014-10-08 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP4840031B2 (ja) 2006-08-31 2011-12-21 ソニー株式会社 ナビゲーション装置、ナビゲーション処理方法及びナビゲーション処理プログラム
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
CL2008000037A1 (es) * 2007-01-16 2008-10-10 Bayer Consumer Care Ag Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos.
US8703204B2 (en) 2007-05-03 2014-04-22 Bend Research, Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
EP2162120B1 (en) 2007-06-04 2016-05-04 Bend Research, Inc Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
CN100536826C (zh) * 2007-12-28 2009-09-09 清华大学 一种绵羊油纳米乳液及其制备方法和应用
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
FR2949063B1 (fr) * 2009-08-11 2011-09-30 Pf Medicament Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale
DE202010004750U1 (de) 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
CN102277748A (zh) * 2010-06-12 2011-12-14 罗莱家纺股份有限公司 纳米维生素微胶囊整理剂的使用方法
KR101494594B1 (ko) 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586789B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP3583954A1 (en) * 2018-06-19 2019-12-25 neubourg skin care GmbH Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds
US12171729B2 (en) 2019-11-25 2024-12-24 The Johns Hopkins University Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumors
CN111388744B (zh) * 2020-01-15 2021-05-18 华中科技大学 一种凝胶贮库及其制法与制备术后止血制剂的应用
BR112022015829A2 (pt) * 2020-02-11 2022-10-25 Advent Therapeutics Inc Composições de palmitato de vitamina a, processos para sua preparação, usos e métodos que as compreendem
WO2021233967A1 (en) * 2020-05-20 2021-11-25 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
WO2021247542A2 (en) * 2020-06-01 2021-12-09 Advent Therapeutics, Inc. Pharmaceutical compositions comprising insoluble active ingredients
KR102628523B1 (ko) 2020-06-30 2024-01-24 주식회사 종근당 GnRH 유도체를 포함하는 주사용 조성물
WO2024165166A1 (en) 2023-02-10 2024-08-15 Tetra Pharm Technologies A cannabinoid-based o/w emulsification system for oral administration targeting endocannabinoid receptors
WO2024208434A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Pressurized nanoemulsion
WO2024208433A1 (en) 2023-04-06 2024-10-10 Biofrontera Bioscience Gmbh Nanoemulsion without propylene glycol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406162A2 (de) * 1989-06-26 1991-01-02 Hans Georg Prof. Dr. Weder Verfahren zur Herstellung einer Nanoemulsion von Oelpartikeln in einer wässrigen Phase
US5658898A (en) * 1994-11-09 1997-08-19 Ciba Geigy Corporation Intravenous solutions for a derivative of staurosporine
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150990A1 (de) 1981-12-23 1983-06-30 A. Nattermann & Cie GmbH, 5000 Köln Neue pflanzenschutzmittelsuspensionskonzentrate
US4675193A (en) * 1983-10-31 1987-06-23 Borden, Inc. Cheese-flavored substance and method of producing same
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
CA1321144C (en) 1986-08-07 1993-08-10 Henrich H. Paradies Pharmaceutical preparations
DE3852409T2 (de) 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
EP0349150B1 (en) * 1988-06-20 1994-08-17 Shiseido Company Limited Transparent compostition
US5338761A (en) * 1988-09-29 1994-08-16 Shiseido Company Ltd. Emulsified composition
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
DK0597007T3 (da) * 1991-07-26 1996-11-18 Smithkline Beecham Corp V/O mikroemulsioner
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
IL101387A (en) 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CH685674A5 (de) 1993-12-19 1995-09-15 Marigen Sa Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit pharmakologisch wirksamen Estern von Apocarotinolen.
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0733372A3 (de) * 1995-03-21 1998-05-20 Ciba-Geigy Ag Pharmazeutische Formulierungsgrundlage für Nanosuspensionen
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
DE19522693A1 (de) 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
JP3508314B2 (ja) * 1995-08-18 2004-03-22 大正製薬株式会社 ビタミンcを配合した液剤
WO1997021428A1 (de) * 1995-12-12 1997-06-19 Vesifact Ag Cortisolspray zur topischen verabreichung
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
DE59710082D1 (de) * 1996-12-13 2003-06-18 Vesifact Ag Baar Kosmetische Präparate in Form einer Nanodispersion
US6028067A (en) * 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0406162A2 (de) * 1989-06-26 1991-01-02 Hans Georg Prof. Dr. Weder Verfahren zur Herstellung einer Nanoemulsion von Oelpartikeln in einer wässrigen Phase
US5698219A (en) * 1994-08-08 1997-12-16 Laboratorios Cusi, S.A. Nanoemulsion of the oil water type, useful as an ophthalmic vehicle and process for the preparation thereof
US5658898A (en) * 1994-11-09 1997-08-19 Ciba Geigy Corporation Intravenous solutions for a derivative of staurosporine

Also Published As

Publication number Publication date
AR019274A1 (es) 2002-02-13
US20060292191A1 (en) 2006-12-28
SG71923A1 (en) 2000-04-18
MY133019A (en) 2007-10-31
KR100622285B1 (ko) 2006-09-11
PL332934A1 (en) 1999-11-22
AU2805099A (en) 1999-11-18
BR9902068B1 (pt) 2014-10-29
HU9901570D0 (en) 1999-07-28
EP0956853A2 (de) 1999-11-17
CN1235017A (zh) 1999-11-17
JP4755742B2 (ja) 2011-08-24
EP0956853A3 (de) 2000-01-05
BRPI9902068B8 (pt) 2021-05-25
US7871642B2 (en) 2011-01-18
ES2253871T3 (es) 2006-06-01
EP0956853B1 (de) 2005-12-14
US20030190347A1 (en) 2003-10-09
CN1220483C (zh) 2005-09-28
US7081253B2 (en) 2006-07-25
ZA993200B (en) 1999-11-11
AU767896B2 (en) 2003-11-27
BR9902068A (pt) 2000-06-06
HUP9901570A2 (hu) 2001-06-28
DE59912910D1 (de) 2006-01-19
CZ166999A3 (cs) 1999-11-17
JPH11335266A (ja) 1999-12-07
ID22565A (id) 1999-11-11
TWI241915B (en) 2005-10-21
ATE312597T1 (de) 2005-12-15
KR19990088156A (ko) 1999-12-27

Similar Documents

Publication Publication Date Title
RU99109958A (ru) Использование нано-дисперсий в составах для фармацевтического применения
Kim et al. Transdermal delivery systems in cosmetics
RU2209618C2 (ru) Нанодисперсия для косметических составов, способ её получения и косметическое средство
ES2382110T3 (es) Formulaciones de espuma exentas de tensioactivo
ES2382890T3 (es) DMS (derma membrane structure) en cremas de espuma.
US5968549A (en) Solubilisation aids
CA2790154C (en) Foam formulations containing at least one triterpenoid
ES2253871T3 (es) Empleo de nanodispersiones en formulaciones farmaceuticas finales.
WO2002022086A2 (en) Application of water nanoclusters to skin
ES2244445T3 (es) Composicion oleosa espumable para la ducha.
JPS5931707A (ja) 両親媒性脂質成分を含む微粉状混合物の製造方法
JPH01193206A (ja) 皮膚の老化に対するアデメチオニンの用途
ES2315541T3 (es) Formulaciones que contienen melatonina, ginkgo biloba y biotina.
EP0554343A1 (fr) Liposomes d'eaux thermales stabilises dans un gel d'adn.
KR100483391B1 (ko) 안정화된 미백 조성물 및 이의 제조 방법
Thy et al. Applications of lecithin in emulsion stabilization and advanced delivery systems in cosmetics: A mini-review
HUT73531A (en) Ketoprofene liposomes
CN101773452B (zh) 结构化乳液
WO2022186343A1 (ja) 外用微粒子カプセル製剤及び皮膚外用剤
FI101600B (fi) Menetelmä farmaseuttisen formulaation valmistamiseksi
JP2025542416A (ja) 陽イオン性物質を含むpH感応型脂質ナノ粒子を含む組成物
JPH06279467A (ja) リン脂質組成物
EP0593562B1 (en) Topical composition containing penciclovir
IE902819A1 (en) Pharmaceutical formulation
EA001116B1 (ru) Быстрорастворимый везикулярный продукт

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180512